Gastric histopathological findings and ghrelin expression in morbid obesity.
نویسندگان
چکیده
OBJECTIVE The role of Ghrelin, also known as the appetite hormone, is not fully explained in the development of morbid obesity. Plasma Ghrelin level is low in obese and high in slim subjects. Ghrelin-expressing cells were investigated histopathologically in the stomach of morbid obese patients in this study. Tissue Ghrelin expression was also compared with various parameters such as the distribution of endocrine cells, age, gender, body mass index, preoperative plasma Ghrelin level and presence of accompanying diseases. MATERIAL AND METHOD The study included 33 morbidly obese patients, and 8 non-obese control patients. Plasma Ghrelin levels were measured preoperatively. Sleeve gastrectomy resection materials of 33 cases were evaluated with histopathological and immunohistochemical (Ghrelin and Chromogranin-A) techniques. The results were statistically evaluated by nonparametric tests. RESULTS Histopathological findings observed in sleeve gastrectomy resection materials were interstitial lymphocytic infiltration (63.6%), hyperplasia of lymphoid follicles in the lamina propria (60.7%) and microvesiculation / dilatation of parietal cells (57.6%). The number of Ghrelin immunopositive cells in the gastric mucosa in females was significantly higher compared to males (p=0,007). Additionally, the number of Ghrelin immunopositive cells was significantly higher at the fundus-proximal corpus compared to the distal corpus of the stomach (p=0.0001). No significant correlation was found between Ghrelin-chromogranin immunopositive endocrine cell distribution and preoperative plasma Ghrelin levels and endocrine cell hyperplasia. CONCLUSION Our study confirms that Ghrelin producing cells are most dense in the proximal stomach. Increased number of Ghrelin expressing cells in the gastric mucosa in females compared to males suggests that gender may also be a factor in determining the method for treatment of morbid obesity.
منابع مشابه
Significant results of using laparoscopic adjustable gastric banding (LAGB) for the treatment of morbid obesity
Background: Morbid obesity contributes to many health risks including physical, emotional, and social problems. The increasing prevalence of obesity is a major public health concern since obesity is associated with several chronic diseases. Morbid obesity is one of the biggest independent risk factors for early mortality. Various options for the surgical treatment of morbid obesity have bee...
متن کاملComparison of roux-en-y gastric bypass techniques with and without distal gastric plication in patients with morbid obesity
متن کامل
Cost-effectiveness of Laparoscopic Sleeve Gastrectomy and Laparoscopic Roux-en-Y Gastric Bypass in Patients with Morbid Obesity: A Systematic Review
Cost-effectiveness of Laparoscopic Sleeve Gastrectomy and Laparoscopic Roux-en-Y Gastric Bypass in Patients with Morbid Obesity: A Systematic Review Talebianpour Hamid1, Shahab Alizadeh2* 1. Ph.D. Student, School of Public Health, Department of Management Sciences and Health Economics, Tehran University of Medical Sciences, Tehran, Iran 2. Ph.D. Student, Faculty of Nutrition and Dietetic...
متن کاملChanges in the gastric ghrelin concentration after whole-abdominal irradiation in rats: Is this related to the radiation-induced anorexia and weight loss?
Background: Ghrelin is a hormone related to food intake in rodents and humans, mainly produced in stomach. This study aimed to determine the effect of irradiation on ghrelin concentration in the gastric mucosa of rats. Materials and Methods : Twenty-five rats were exposed to 15 Gy of whole-abdominal irradiation. Gastric tissue samples were obtained 1, 3, 7, 30, and 90 days after irradiation. Fi...
متن کاملSleeve gastrectomy for morbid obesity.
The rising prevalence of morbid obesity and the increased incidence of super-obese patients (BMI >50 kg/m2) seeking surgical treatments has led to the search for surgical techniques that provide adequate EWL with the least possible morbidity. Sleeve gastrectomy (SG) was initially added as a modification to the biliopancreatic diversion (BPD) and then combined with a duodenal switch (DS) in 1988...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Turk patoloji dergisi
دوره 29 1 شماره
صفحات -
تاریخ انتشار 2013